InspireMD is a medical company that has developed a system to prevent embolism during carotid artery stenting. Its stock price reflects the pace of adoption of this technology by surgeons and its potential to become a new standard of care for stroke prevention.
InspireMD is developing and commercializing the CGuard™ stent system with MicroNet technology for stroke prevention in the treatment of carotid artery stenosis. We classify it as "Specialized Medical Equipment." The chart below shows the dynamics of this innovative segment.
InspireMD is a medical device company that developed the CGuard embolism protection system for use in carotid artery stenting. As an innovator, it is included in our GURU.Markets index. The chart below shows the overall market trend. Compare it with InspireMD's performance to assess the state of the sector.
Daily fluctuations in InspireMD, Inc., a manufacturer of medical stents, reflect volatility in the medical device sector. This indicator, a measure of sensitivity to clinical data and regulatory approvals, serves as the basis for analysis on System.GURU.Markets.
InspireMD, Inc. is a medical device company. This chart illustrates the high volatility of the MedTech industry. Comparing it to NSPR, which focuses on carotid artery treatment, helps assess the extent to which its innovative products contribute to its volatility.
InspireMD develops stents to prevent strokes. It's an innovative medtech company whose stock price responds to clinical successes and regulatory decisions. Its history reflects the medtech sector's contribution to overall market volatility.
InspireMD, Inc.'s year-over-year performance is the story of its CGuard stent system for stroke prevention. Its market capitalization growth over the past 12 months reflects increased sales in Europe and progress toward FDA approval in the US. The success of its embolism-protecting technology could make it the new standard in carotid stenting.
InspireMD, Inc. is a medical device company that has developed a stroke prevention technology. Its success depends on surgeon adoption and insurance coverage. The chart below shows how its innovative technology and competition in this important field influence its volatile performance.
InspireMD, with its stroke prevention system, is a growth story in medicine. Its stock price is driven not by the economy, but by the speed of adoption by doctors and the insurance system. The chart reflects the potential of this breakthrough technology in the vast cardiology market, regardless of the economic climate.
InspireMD develops and markets stent systems for stroke prevention. Its monthly performance reflects progress in the commercialization of its flagship product, CGuard. Key drivers include regulatory approvals in new markets (particularly the US), sales growth, and clinical trial data.
InspireMD develops and manufactures stent systems with MicroNet technology to prevent stroke in patients with carotid stenosis. This technology is designed to make stenting procedures safer. The graph below shows the dynamics of the medical device sector, where patient safety is a top priority.
InspireMD develops stents to prevent strokes. As a medical technology company, its growth depends on the adoption of its products by surgeons and regulatory approvals in various countries. Share price performance is determined by these specific factors, not by general market cycles.
InspireMD, Inc., a manufacturer of stroke prevention stents, whose weekly stock price reflects progress in medicine. News about clinical trials, regulatory approvals in the US and Europe, and sales data shape short-term trends, demonstrating demand for innovative medical devices.
InspireMD develops stent systems to prevent strokes. Success in the medical device sector depends on approvals and technology adoption. This chart will show whether the weekly stock price movement is driven by company news or simply follows the general sentiment in the medical technology industry.
InspireMD is a medical device company. The healthcare sector is considered defensive, but small companies can be volatile. This chart will help you assess whether InspireMD shares move in tandem with the market or are driven by unique product and sales news.
InspireMD's market capitalization is a financial roadmap for the fight against stroke. Its chart reflects investors' faith in its carotid artery stenting technology, which is designed to prevent blood clots. Its performance is a barometer of progress in clinical trials and regulatory approvals for its innovative medical device.
InspireMD's market share in the medical device sector demonstrates its position as a highly specialized player. The company focuses on stroke prevention with its advanced stent systems. Its market share reflects its technological superiority in a crucial medical niche.
InspireMD develops stents to prevent strokes. The chart below shows the overall market capitalization of the entire medical device sector. Its growth reflects the aging population and the ongoing need for innovative solutions to treat cardiovascular diseases.
InspireMD produces the CGuard embolism protection system for stroke prevention during carotid artery stenting. Its market capitalization is based on its unique technology. The chart below shows the economic weight of vascular protection device manufacturers.
The book value of InspireMD, a manufacturer of medical stents, is represented by its production lines and inventory. The chart below shows the physical assets of its innovative business. Growth reflects investments in production expansion to meet demand for its unique stroke protection technology.
InspireMD produces stents with unique embolism protection technology. Manufacturing these high-tech medical devices requires certified clean rooms and production lines. The asset share chart shows how the company is investing in building its unique physical infrastructure.
InspireMD is a medical device company. It has its own manufacturing facilities to create its unique stents. This makes it more capital-intensive than pure R&D startups. The graph will show whether this model (science and manufacturing) is the norm for the entire medical device industry.
InspireMD's balance sheet consists of manufacturing facilities and patents for a unique carotid artery stenting system that prevents strokes. The company's assets are the capital embodied in its brain protection technology. The chart shows its manufacturing and scientific footprint in the vascular surgery niche.
InspireMD develops stent systems to prevent strokes. Its balance sheet reflects R&D and manufacturing costs, but the market values its patented MicroNet technology. The chart shows how investors assess the potential of this device to become a new standard in carotid artery treatment and capture a share of the vast medical market.
InspireMD develops stent systems to prevent strokes. The company combines manufacturing assets with proprietary technology. This metric demonstrates how the market values its medical innovation. A market value exceeding book value indicates confidence in the superiority of its technology over competitors.
InspireMD develops and manufactures stenting systems for stroke prevention. This chart shows how the market values this medical device with its unique protection technology. The market capitalization premium to book value reflects the value of its patents and investor confidence that its product will become a new standard in carotid artery treatment.
InspireMD develops and markets embolism protection systems for use in cardiac procedures. For a medical technology company, debt can be a tool for funding clinical trials to secure approvals in new regions and expanding its sales team. This chart shows the company's investments in commercializing its technologies.
InspireMD develops and manufactures stent systems for stroke prevention. In the medical device industry, bringing a new product to market is a lengthy process, including clinical trials and regulatory approvals. This chart illustrates industry financial norms, where companies raise capital to fund these critical milestones.
InspireMD develops and markets medical stents for stroke prevention. Bringing such devices to market requires significant investment in manufacturing, clinical research, and marketing. This chart shows how the company manages its debt to finance these processes, allowing us to assess its financial strength as it seeks commercial success.
Developing medical devices to prevent strokes, InspireMD's specialty, requires investment in engineering and lengthy clinical trials. This chart shows the overall debt burden in the medical device sector. It helps understand how the company finances its innovative products and how its financial strategy compares to industry giants.
InspireMD develops and manufactures medical stents for carotid arteries. Developing and commercializing medical devices requires significant capital for research, testing, and production. The chart shows how their debt policy for funding this process differs from the market average.
This chart shows the valuation of InspireMD, Inc., a company that produces medical devices for stroke prevention. In the medical device sector, this metric reflects how investors view a company's technology and its ability to capture market share from competitors. It is an indicator of confidence in the commercial potential of its products.
This chart shows the average valuation for the specialized medical device industry, where InspireMD operates. This metric reflects how investors generally view the growth and innovation prospects in this industry. It helps understand whether the market values InspireMD's technology above or below competitors' solutions.
InspireMD develops and markets embolism protection systems used in carotid artery stenting to prevent strokes. The company's growth depends on the acceptance of its technology by the medical community. This chart shows the overall sentiment in the healthcare sector and helps understand whether InspireMD's valuation reflects its technological advantage in an important medical niche.
InspireMD develops and markets micromesh-based embolic protection systems designed to prevent strokes during carotid artery stenting procedures. The company's future growth depends on surgeon adoption of its technology. This chart shows how investors view the clinical benefits of its products and the potential for gaining market share in vascular surgery.
%20P%2FE%20InspireMD%2C%20Inc.&width=1500&height=450&colorIndex=35&v=mr7eoit3.lf-6of3yf4&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-InspireMD-Inc. "Chart of the company's future (projected) P/E InspireMD, Inc.")
InspireMD develops and manufactures microgrid-based embolism protection systems for use in cardiovascular surgery. This technology is designed to make carotid artery surgeries safer. The chart shows expectations for the medical device sector, helping to understand how the market perceives the potential of this innovative technology to improve treatment outcomes.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20&width=1500&height=450&colorIndex=36&v=mr7eoit3.lf-6of3yf4&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment "Future (projected) P/E graph of the market segment -")
InspireMD develops and manufactures embolic protection systems used in carotid artery stenting. Their success depends on the implementation of new medical technologies. This overall expectations chart reflects the healthcare system's willingness to invest in innovation. Market optimism suggests that hospitals and physicians will be more willing to adopt safer and more effective devices like InspireMD's.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&v=mr7eoit3.lf-6of3yf4&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole "Chart of the future (projected) P/E of the market as a whole")
InspireMD develops and manufactures microgrid-based embolic protection systems for use in cardiovascular procedures. This graph reflects the commercialization of its unique technology. Revenue growth depends on the clinical adoption of its products, approvals in new regions, and convincing surgeons of the benefits of its technology.
WiMi Hologram Cloud Inc. is a Chinese company working in the field of holographic augmented reality (AR). Profitability in this futuristic niche depends on the creation of real commercial applications. This chart illustrates the state of the nascent market, where enormous expectations and investments have not yet translated into stable revenue and profitability for most players.
InspireMD develops innovative stent systems to prevent strokes. Demand for such vital medical products is driven by demographic trends and healthcare needs, not by economic conditions. Therefore, looking at this chart of general market fluctuations, one can assess the stability of a business solving fundamental problems in medicine.
InspireMD develops and markets MicroNet technology-based embolism (microstroke) protection systems for carotid artery stenting procedures. The company's revenue projections depend on the clinical adoption of its technology. This chart shows analysts' estimates of the carotid stenting market growth potential and the uniqueness of InspireMD's technology.
%20profit%20of%20the%20company%20InspireMD%2C%20Inc.&width=1500&height=450&colorIndex=41&v=mr7eoit3.lf-6of3yf4&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-InspireMD-Inc. "Graph of future (projected) profit of the company InspireMD, Inc.")
InspireMD develops and markets stents with MicroNet technology to prevent strokes in patients with carotid artery stenosis. This innovative solution addresses a serious medical problem. This chart shows profitability forecasts for the medical device sector. It helps assess how quickly advanced technologies like InspireMD can gain market share.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20&width=1500&height=450&colorIndex=42&v=mr7eoit3.lf-6of3yf4&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment "Graph of future (predicted) profits of companies in a market segment -")
InspireMD develops and manufactures embolic protection systems for vascular procedures. Demand for their specialized medical equipment is less dependent on economic cycles. However, the profit projections shown in the graph influence hospital budgets and their willingness to invest in new, more advanced patient safety technologies.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&v=mr7eoit3.lf-6of3yf4&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole "Chart of future (predicted) profits of the market as a whole")
InspireMD develops and markets embolism protection systems used in carotid artery stenting to prevent strokes. The company's revenue depends on the clinical adoption of its technology. This chart shows how investors value its sales, betting on the superiority of its technology and the growth of the minimally invasive vascular procedures market.
InspireMD, Inc. is a medical device company that developed the CGuard™ stenting system for preventing strokes by treating carotid artery stenosis. The company's revenue depends on the adoption of its technology in hospitals. This chart reflects the average valuation for the sector, providing insight into how the market values InspireMD's innovative solutions.
InspireMD develops and markets embolic protection systems (CGuard) used in carotid artery stenting to prevent strokes. This chart helps assess the market's willingness to value the company's revenue for this innovative solution for a critical medical procedure, compared to the market average.
InspireMD develops and manufactures embolic protection systems (CGuard) used in carotid artery stenting to prevent strokes. This chart shows investor estimates for the company's future revenue. It reflects expectations for the clinical adoption of CGuard technology and increased sales of this medical device.
%20P%2FS%20InspireMD%2C%20Inc.&width=1500&height=450&colorIndex=47&v=mr7eoit3.lf-6of3yf4&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-InspireMD-Inc. "The graph of the company's future (projected) P/S InspireMD, Inc.")
InspireMD develops and manufactures MicroNet-based embolic protection systems used in carotid artery stenting to prevent strokes. This chart compares InspireMD's estimated future sales with those of other medical device manufacturers, reflecting how investors view the potential of its unique technology in cardiac surgery.
%20P%2FS%20market%20segment%20graph%20-%20&width=1500&height=450&colorIndex=48&v=mr7eoit3.lf-6of3yf4&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph "Future (projected) P/S market segment graph -")
Investor sentiment regarding future revenue depends on innovations in cardiovascular treatment. InspireMD is developing a technology to protect the carotid arteries from strokes. Clinical implementation of their devices could significantly improve treatment outcomes, demonstrating how medical technology contributes not only to health but also to economic growth.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&v=mr7eoit3.lf-6of3yf4&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole "Chart of the future (projected) P/S of the market as a whole")
InspireMD develops and markets innovative CGuard stent systems for stroke prevention in patients with carotid artery disease. The company generates revenue from sales of these medical devices to hospitals and clinics. This chart shows how the implementation of its unique technology in medical practice contributes to financial growth.
InspireMD develops and commercializes CGuard EPS, an embolic protection technology used to prevent strokes during carotid artery stenting. This chart shows total revenue in the specialty medical device sector. It reflects the need for safer and more effective solutions in cardiovascular surgery, where InspireMD offers its innovation.
InspireMD develops and manufactures micromesh stent technology to prevent strokes in patients with carotid artery stenosis. The company's success depends on the acceptance of its technology by surgeons and hospitals. This economic climate impacts healthcare system budgets and their ability to purchase new, safer, and more effective medical equipment.
InspireMD develops and manufactures micromesh stenting systems to prevent strokes in patients with carotid stenosis. The company's growth depends on the adoption of its technology by surgeons. This chart shows analyst revenue expectations, reflecting their forecasts for carotid stenting market growth and market share gains for the company's products.
%20sales%20of%20the%20company%20InspireMD%2C%20Inc.&width=1500&height=450&colorIndex=53&v=mr7eoit3.lf-6of3yf4&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-InspireMD-Inc. "Schedule of future (projected) sales of the company InspireMD, Inc.")
InspireMD is developing a stenting technology to prevent strokes in patients with carotid artery disease. The company's success depends on the introduction of its product into clinical practice. This chart shows projected sales for the entire specialized medical equipment segment, reflecting overall expectations for the cardiovascular device market.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20&width=1500&height=450&colorIndex=54&v=mr7eoit3.lf-6of3yf4&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment "Schedule of future (projected) sales of companies in the market segment -")
InspireMD develops stent graft technology to prevent strokes in patients with carotid artery stenosis. Demand for its products is determined by healthcare system budgets and physician adoption of the technology. This general economic activity influences public and private healthcare spending, which impacts the purchase of new equipment.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&v=mr7eoit3.lf-6of3yf4&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole "Schedule of future (predicted) sales of the market as a whole")
InspireMD develops and markets innovative stent systems for stroke prevention. This metric reflects the commercial viability of its medical technologies. It shows what percentage of revenue from sales of its specialized devices the company converts into net profit, which reflects its pricing policy and control over production costs.
InspireMD develops and manufactures microgrid-based embolism protection systems to prevent strokes during cardiac procedures. Profitability depends on surgeon adoption of this technology. This metric demonstrates the operational efficiency of the company's business model compared to other manufacturers of specialized medical equipment.
InspireMD develops and commercializes stenting technology to prevent strokes in patients with carotid artery insufficiency. Their growth depends on the adoption of this technology by physicians and hospitals. This overall profitability curve impacts them through healthcare system budgets, which are more willing to invest in new medical technologies in a stable economic environment.
InspireMD develops and markets innovative stent systems for stroke prevention. This chart shows how the medical technology company is building its workforce. The growth of its engineering team, clinical research specialists, and, most importantly, sales team is directly tied to product launch and clinical adoption.
InspireMD develops micron mesh stents to prevent strokes. This chart shows the percentage of engineers and clinicians in the vascular surgery niche that the company attracts. Its team is at the forefront of intellectual development, creating technology designed to make carotid artery surgery safer.
InspireMD, Inc. develops and commercializes stenting technology to prevent strokes in patients with carotid artery stenosis. This chart shows overall employment in the specialized medical device sector. Its growth reflects the ongoing pursuit of safer and more effective treatments for cardiovascular disease.
InspireMD develops and manufactures embolism protection systems for carotid artery stenting, preventing strokes. This highly specialized medical technology requires highly skilled engineers and physicians. This graph shows overall employment, where the high-tech medical equipment sector contributes by creating jobs for elite specialists.
InspireMD, Inc. develops and manufactures stent systems for stroke prevention. This chart shows how the market values the company's intellectual capital and patents. A high PE ratio is typical for high-tech medical equipment manufacturers, where a small team of engineers and scientists creates a product with enormous market potential.
%20of%20the%20company%20InspireMD%2C%20Inc.%20(NSPR)&width=1500&height=450&colorIndex=63&v=mr7eoit3.lf-6of3yf4&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-InspireMD-Inc.-NSPR "Chart of market capitalization per employee (in thousands of dollars) of the company InspireMD, Inc. (NSPR)")
InspireMD develops and commercializes embolism protection technology for cardiovascular procedures. In the medical device sector, this metric reflects the value of their patents and technologies. A high metric may indicate a company possesses a unique technology that can capture significant market share, justifying a high valuation per employee.
%20by%20market%20segment%20-%20&width=1500&height=450&colorIndex=64&v=mr7eoit3.lf-6of3yf4&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment "Market capitalization per employee (in thousands of dollars) by market segment -")
InspireMD, Inc. develops and manufactures embolic protection systems for use in cardiovascular surgery. It is a niche medical technology company. Its valuation per employee reflects the value of its proprietary technology and its potential to improve surgical outcomes and save patient lives.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&v=mr7eoit3.lf-6of3yf4&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market "Market capitalization per employee (in thousands of dollars) for the overall market")
InspireMD is a medical device company. They developed and market the CGuard stent system, designed to prevent strokes in patients with carotid artery disease. This chart shows how effectively their sales and manufacturing teams work together, measuring net profit per employee.
%20Chart%20InspireMD%2C%20Inc.%20(NSPR)&width=1500&height=450&colorIndex=66&v=mr7eoit3.lf-6of3yf4&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-InspireMD-Inc.-NSPR "Company Profit Per Employee (in thousands of dollars) Chart InspireMD, Inc. (NSPR)")
InspireMD produces innovative CGuard stents for stroke prevention. In the medical device sector, this chart is a direct indicator of commercial performance. It reflects how effective NSPR's sales team is in promoting their patented technology to surgeons and hospitals, and how profitable their manufacturing is compared to industry competitors.
%20in%20the%20market%20segment%20-%20&width=1500&height=450&colorIndex=67&v=mr7eoit3.lf-6of3yf4&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment "Chart of profit per employee (in thousands of dollars) in the market segment -")
InspireMD (NSPR) develops and manufactures medical devices, specifically the CGuard stent system for stroke prevention. Their business is focused on the high-tech production and sales of medical equipment. This metric reflects how effectively their team (engineers, production, and sales) generates profit from each high-margin device sold.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&v=mr7eoit3.lf-6of3yf4&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole "Chart of profit per employee (in thousands of dollars) for the market as a whole")
This chart for InspireMD, a manufacturer of embolic protection systems for stenting, demonstrates the commercial success of its medical device. The growth in revenue per employee indicates growing acceptance of its technology by surgeons and the company's ability to efficiently manufacture and market its products.
&width=1500&height=450&colorIndex=69&v=mr7eoit3.lf-6of3yf4&filename=GURU_Markets_-_Sales-chart-per-company-employee-InspireMD-Inc.-NSPR "Sales chart per company employee InspireMD, Inc. (NSPR)")
InspireMD develops and markets medical devices, specifically carotid artery stents (CGuard). It is a high-tech medtech company. This metric measures average revenue per employee by segment. It helps evaluate how productive InspireMD's R&D and sales teams are in commercializing their devices compared to other medical device manufacturers.
InspireMD (NSPR) manufactures and markets innovative CGuard™ stent systems for stroke prevention. This metric reflects the commercial effectiveness of their dedicated sales and marketing team. The growth in revenue per employee demonstrates that their unique micromesh stent technology is gaining increasing acceptance among surgeons and is successfully penetrating the market.
InspireMD develops medical devices, specifically CGuard mesh stents for stroke prevention during carotid artery surgery. It's a highly competitive market dominated by medical device giants. This chart reflects investor bets that InspireMD will fail to capture significant market share or will face challenges in obtaining regulatory approvals.
&width=1500&height=450&colorIndex=72&v=mr7eoit3.lf-6of3yf4&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-InspireMD-Inc.-NSPR "Short Shares Chart for the Company InspireMD, Inc. (NSPR)")
InspireMD (NSPR) is a medical device company that developed the CGuard stent system for preventing strokes in patients with carotid artery disease. This chart shows the total short position in the specialized medical device sector. It reflects market concerns about the speed of adoption of this technology by surgeons and the level of reimbursement from insurance companies.
InspireMD (NSPR) develops carotid artery stents. This would seem to be a crucial medical technology. But NSPR is a small, unprofitable company. When this chart shows rising panic, investors aren't market-savvy. They're selling off all their unprofitable medical technology companies, fearing the risks of financing.
InspireMD is a medical technology company that has developed a unique carotid stent (CGuard) that prevents strokes. Their success is driven by a race for FDA approval and market share. This chart measures how investors view their chances. It shows when the stock is overbought on approval expectations or oversold on fears.
&width=1500&height=450&colorIndex=75&v=mr7eoit3.lf-6of3yf4&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-InspireMD-Inc.-NSPR "RSI 14 indicator chart for the company's stock InspireMD, Inc. (NSPR)")
InspireMD (NSPR) is a "net" for arteries. They make stents (CGuard EPS) that catch debris (emboli) during carotid artery stenting (stroke protection). The "Specialized Medical Equipment" (medtech) sector thrives on R&D. RSI_14_Seg shows whether the entire sector is "overbought." This helps differentiate: is NSPR's growth a niche product or a general "overheating"?
InspireMD (NSPR) produces medical devices. This chart shows that its business is "defensive." Demand for its products (stents) isn't driven by euphoria or panic—it's driven by the need for surgeries. During times of market panic, investors seek safe havens in companies with non-cyclical demand.
InspireMD produces the CGuard system, a stent designed to prevent stroke by protecting the carotid artery. This chart shows the analysts' average forecast. Their targets are based on the pace of CGuard adoption in Europe and, more importantly, potential approval and launch in the US.
&width=1500&height=450&colorIndex=78&v=mr7eoit3.lf-6of3yf4&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-NSPR-InspireMD-Inc. "A chart showing analyst consensus forecasts for the expected stock price. NSPR (InspireMD, Inc.)")
InspireMD is a medical technology company that developed the CGuard stent. Its unique "micromesh" is designed to prevent strokes in patients with carotid arteries. This chart shows the upside and downside potential analysts see in the stock. It measures the gap between the price and forecast, reflecting their belief in the adoption of this technology in cardiac surgery.
&width=1500&height=450&colorIndex=79&v=mr7eoit3.lf-6of3yf4&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-NSPR-InspireMD-Inc. "A chart showing the difference between the consensus forecast and the actual stock price. NSPR (InspireMD, Inc.)")
InspireMD is a medical device company that developed the CGuard stent (with a micromesh) for stroke prevention in patients with carotid arteries. This chart reflects general expectations for the specialized medical device sector, showing whether experts believe this technology is superior to traditional stents.
InspireMD (NSPR) is a medical technology company focused on protecting the brain. They developed CGuard, a next-generation mesh stent for carotid arteries that prevents strokes during surgery. This chart shows the overall risk appetite, reflecting the market's willingness to fund companies whose breakthrough medical technologies are changing the standard of care.
InspireMD is a MedTech company focused on protecting the brain. Their signature product (CGuard) is a carotid artery stent (for stroke prevention) that features a unique micro-mesh designed to trap dangerous debris (emboli). This chart summarizes their implementation history, reflecting their (slow) progress toward FDA approval and their battle for market share.
InspireMD develops stents with C-Guard technology, which prevents embolism (vascular occlusion) during and after carotid artery stenting. This chart shows the average index for the specialized medical equipment sector. It helps assess how InspireMD's technology performs compared to the average.
InspireMD is a manufacturer of next-generation stents (MicroNet technology) for stroke prevention in carotid artery treatment. This chart, reflecting the market average, is a backdrop. It helps assess how this MedTech company, which aims to change the standard of care, compares to overall macroeconomic trends.
